Pfizer's new at-home pill to treat Covid could be available by end of the year, CEO hopes
The company in March began an early stage clinical trial testing a new antiviral therapy for Covid.
Lucien Lee mark this message contains personal perspective
｜originally written by Lucien Lee
輝瑞公司 CEO Albert Bourla 的確表示他們正在研發一種用於治療COVID-19症狀的口服藥物，「有可能會在」今年(2021)年底之前向公眾提供。該公司在新聞稿中表示，口服藥物可通過阻斷蛋白酶來起作用，蛋白酶是病毒能在體內複製的關鍵要素，該抑制劑藉由抑制蛋白酶，來阻撓病毒增生、防止病情惡化，HIV、C型肝炎藥物也都是使用蛋白酶抑制劑。
同時，CEO Albert Bourla 說該藥「可能」對新興的變種有效。
但該藥還在臨床實驗階段，還沒有任何相關實驗成果釋出。
同時，CEO Albert Bourla 說該藥「可能」對新興的變種有效。
但該藥還在臨床實驗階段，還沒有任何相關實驗成果釋出。
Opinion Sources
- CNBC 報導 https://www.cnbc.com/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html- WebMD 報導 https://www.webmd.com/lung/news/20210428/pfizer-developing-pill-to-treat-covid-19-symptoms
https://www.cnbc.com/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html
https://www.webmd.com/lung/news/20210428/pfizer-developing-pill-to-treat-covid-19-symptoms
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.